Amgen Inc. (AMGN) Q4 2023 Earnings Results

Amgen Beats on EPS, Stock Down 1.83%

Amgen's earnings report shows a slight beat on EPS, indicating better-than-expected profitability. However, the stock fell by 1.83% in reaction, likely due to the lack of revenue details and forward guidance. Investors may be concerned about competitive pressures and the absence of specific future targets.

The print

Key numbers

Actual vs. consensus

Metric	Actual	Expected	Surprise
EPS	$4.71	N/A	+1.16%
Revenue	N/A	N/A	N/A

Management

Management commentary

Tone: Cautiously Optimistic

Overall, management expressed a cautious optimism about future growth. They are focusing on their product pipeline and operational improvements despite competitive challenges.

Management highlighted ongoing efforts to enhance product pipeline.

They acknowledged competitive pressures but emphasized strong market position.

Focus remains on innovation and operational efficiency.

Amgen Beats on EPS, Stock Down 1.83%

Key numbers

Management commentary

Amgen Inc.

More earnings this week

Amgen Beats on EPS, Stock Down 1.83%

Key numbers

Management commentary